PIPCU officers raided a Lancashire fulfilment centre on 28 August and seized items believed to be counterfeit Ozempic, Mounjaro and Retatrutide. Detectives report the products contained four times the recommended dose, creating serious health risks. Retatrutide remains in phase three clinical trials and has not been approved by any regulator worldwide. The seized products were being shipped without MHRA licensing or any health checks. Mounjaro (tirzepatide) and Ozempic (semaglutide) are prescription-only in the UK and should be obtained only after consultation and screening by a registered healthcare professional. The public is asked to contact the City of London Police with any information or if they purchased counterfeit medicine.
The force's Police Intellectual Property Crime Unit (PIPCU) raided a Lancashire-based fulfilment centre on 28 August, seizing what officers believe to be counterfeit Ozempic, Mounjaro and another drug, Retatrutide. Detectives say the products contained four times the recommended dose, posing serious health risks. Retatrutide is still in phase three clinical trials and has not been approved by any regulator worldwide.
Detective Constable Jason Theobald, of PIPCU, said: Members of the public must be aware of the very real dangers of purchasing counterfeit or unlicenced medicines such as Mounjaro or Ozempic online. Not only are they potentially unsafe, but they could also be sold without the necessary medical advice and therefore are extremely dangerous to the public. Anyone with information or who may have purchased counterfeit medicine, is encouraged to contact the City of London Police immediately.
Collection
[
|
...
]